Skip to content
Belgian Medicines Verification Organisation

Belgian Medicines Verification Organisation

VZW

  • Home
  • BeMVO
    • Governance
    • Members
    • EMVO
    • Medicines Verification System
  • MAH
    • Marketing Authorization Holders (MAH)
    • Registration MAH
  • End Users
    • On boarding of end users
      • Wat is an end user?
      • Who are the end users of the verification system?
      • HOW CAN END USERS ON BOARD TO THE VERIFICATION SYSTEM
      • Contractual on boarding by end users
      • Development portal and implementation support
      • Access Request Verification by BeMVO – Contractual part
      • Development of the access module
      • Technical implementation
    • End user access to the Medicines Verification System
    • End User – SOFTWARE SUPPLIERS
  • FAQ
  • News
  • Contact
  • en
    • nl
    • fr

Communication from RIZIV/INAMI

Communication from RIZIV/INAMI regarding the availability on the market of FMD packs containing only the 2D matrix code (without the linear barcode).

https://www.inami.fgov.be/SiteCollectionDocuments/omzendbrief_apothekers_24.pdf

https://www.inami.fgov.be/SiteCollectionDocuments/circulaire_pharmaciens_24.pdf

Posted by Anne Carion / October 31, 2018 / 0 Comments / Tagged with 2D Matrix code, Riziv / Posted in News

Update – Incidents management for End Users and Software Suppliers

Technical document for End Users and Software Suppliers on how to handle incidents and alerts being generated by the Verification system.

NMVS – Incidents mngt – 20181001

Posted by Anne Carion / October 3, 2018 / 0 Comments / Tagged with NMVS / Posted in News

Update Falsification Alerts management

Procedure to be followed by all stakeholders in case of an alert indicating a potential falsification.

FMD – Falsification alerts – 20181001

 

Posted by Anne Carion / October 3, 2018 / 0 Comments / Tagged with Alerts, FMD / Posted in News

Safety Features For Medicinal Products for Human Use – QA version 11

This document sets out frequently-asked questions and answers regarding the implementation of the rules on the safety features for medicinal products for human use https://bemvo.be/qa_safetyfeature_en_v11/

Posted by Anne Carion / October 2, 2018 / 0 Comments / Tagged with safety / Posted in News

Search

Recent Posts

  • INTERPOL warns of organized crime threat to COVID-19 vaccines
  • COVID-19
  • Safety Feature
  • Finnish customs lead a European wide operation combatting falsified medicines
  • Transition period

Recent Comments

    Archives

    • December 2020
    • March 2020
    • May 2019
    • February 2019
    • January 2019
    • December 2018
    • October 2018
    • June 2018
    • May 2018
    • February 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017
    • August 2017
    • July 2017

    Categories

    • News

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    © Copyright 2021


    DISCLAIMER – All information on this website is based on the current available understanding and interpretation of the Directive 2011/62/EU and the Delegated Regulation 2016/161 by the European and Belgian competent authorities and by the stakeholder associations at European and Belgian level. Final conclusions and legislation emitted by the competent authorities might result in a different application of the Directive and Delegated Regulation in Belgium.

    Site by DataConnect.be

    COVID-19

     

    Omwille van COVID-19 zijn de kantoren van BeMVO niet altijd telefonisch beschikbaar.
    Daarom is het aangewezen om BeMVO best via email te contacteren voor alle vragen.

    A cause de COVID-19, le bureau BeMVO n’est pas toujours joignable par téléphone.
    Pour cette raison nous vous conseillons de contacter BeMVO de préférence par email pour toute question.

    Due to Covid-19, you can not always contact our office by phone.
    We kindly invite you to use following email addresses for questions

    Wholesalers :  whs@bemvo.be

    Pharmacies:    pha@bemvo.be

    Hospitals:        hosp@bemvo.be

    MAH:               MAH@bemvo.be

    Dank voor uw begrip.
    Nous vous remercions pour votre compréhension.
    Thank you.

    We use cookies to ensure that we give you the best experience on our website, to provide personal recommendations and to analyse our traffic using Google Analytics. If you continue to use this site you agree to this. I agree